Loading…
Ingevity Corporation is projected to rise to $82.68 by 2027, a +15% move from its current price of $72.19. NGVT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $71.02 | $72.23 | $73.46 | +0.05% |
| Jul 14 | $70.56 | $72.26 | $74.01 | +0.10% |
| Jul 15 | $70.21 | $72.30 | $74.44 | +0.15% |
| Jul 16 | $69.93 | $72.33 | $74.82 | +0.20% |
| Jul 17 | $69.69 | $72.37 | $75.16 | +0.25% |
| Jul 18 | $69.47 | $72.41 | $75.47 | +0.30% |
| Jul 19 | $69.28 | $72.44 | $75.75 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $69.28 | $72.44 | $75.75 | +0.35% |
| Week 2 | $68.25 | $72.70 | $77.44 | +0.70% |
| Week 3 | $67.52 | $72.95 | $78.82 | +1.06% |
| Week 4 | $66.95 | $73.21 | $80.05 | +1.41% |
| Week 5 | $66.48 | $73.47 | $81.19 | +1.77% |
| Week 6 | $66.08 | $73.72 | $82.25 | +2.13% |
| Week 7 | $65.73 | $73.98 | $83.27 | +2.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats.
This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications.
The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.
It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors.
The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Ingevity Corporation (NGVT) is a Basic Materials company with a current price of $71.53 and a market capitalization of $2.49B. It holds a market rank of 1889. These figures reflect the company’s standing in the market today as it continues to operate across its three business segments.
The price outlook shown in the provided forecast is bullish over the longer term, with a path of rising averages and substantial upside through 2030, 2040, and 2050. The 2026 forecasted average is aligned with the current price, underscoring a flat-to-bullish near-term view that broadens into significant upside later in the decade and beyond.
A major floor 16.1% below — a decisive break under it would weaken the trend.
The nearest floor, 8.6% below — buyers have tended to step in here.
The nearest ceiling, 6.8% above — a clean break opens room to run.
A major ceiling 14.8% above — clearing it would confirm fresh momentum.
Key NGVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NGVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $72.60 | Sell | $72.44 | Sell |
| MA 10 | $73.39 | Sell | $72.74 | Sell |
| MA 20 | $73.02 | Sell | $72.39 | Sell |
| MA 50 | $71.21 | Buy | $71.55 | Buy |
| MA 100 | $71.08 | Buy | $69.89 | Buy |
| MA 200 | $64.73 | Buy | $65.31 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.86 | Neutral |
| Stoch RSI (14) | 8.10 | Buy |
| CCI (20) | -56.90 | Neutral |
| Williams %R (14) | -90.34 | Info |
| MACD (12,26,9) | -0.27 | Sell |
| ROC (12) | -0.81 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 9.66 | Buy |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | 1.93 | Buy |
| Ultimate (7,14,28) | 38.70 | Neutral |
| Momentum (10) | -2.10 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 71.80 | Buy |
| ADX (14) | 12.83 | Neutral |
| ATR (14) | 1.12 | Info |
The 30-day technical picture is mixed but leaning bullish, with a current RSI of 50. The short‑term moving averages sit at SMA50 $71.34 and SMA200 $64.58, suggesting near-term support around the mid-$60s. The key support level is $65.99 and the resistance is $77.12, framing a 30-day range from $63.58 to $80.47.
Overall, sentiment remains bullish while near-term momentum is modest.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $60.09 | $72.19 | $94.82 | 0% | Neutral | |
| $67.71 | $82.68 | $105.55 | +15% | Neutral | |
| $76.55 | $95.22 | $124.85 | +32% | Bullish | |
| $88.24 | $111.47 | $149.26 | +54% | Bullish | |
| $100.51 | $128.68 | $175.41 | +78% | Bullish | |
| $119.90 | $155.37 | $215.14 | +115% | Bullish | |
| $129.64 | $169.90 | $238.60 | +135% | Bullish | |
| $134.37 | $177.95 | $253.14 | +147% | Bullish | |
| $147.27 | $196.97 | $283.55 | +173% | Bullish | |
| $147.85 | $199.61 | $290.56 | +177% | Bullish | |
| $243.04 | $342.25 | $522.06 | +374% | Bullish | |
| $451.60 | $682.03 | $1,115.19 | +845% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $60.09 | $72.19 | $88.01 | +0.00% |
| August 2026 | $64.61 | $75.64 | $90.48 | +4.78% |
| September 2026 | $64.24 | $75.56 | $91.09 | -0.10% |
| October 2026 | $65.50 | $77.36 | $93.86 | +2.38% |
| November 2026 | $66.44 | $78.74 | $96.07 | +1.79% |
| December 2026 | $65.04 | $77.33 | $94.82 | -1.79% |
Click any year to see its month-by-month NGVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NGVT is projected to trade between $60.09 and $94.82, averaging $72.19 — a potential gain of 0% from today's $72.19. Price action looks broadly range-bound.
Ingevity Corporation's 2027 outlook centres on $82.68, within a $67.71 to $105.55 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, NGVT could reach as high as $124.85, with a base case around $95.22 and support toward $76.55 — roughly +32% from $72.19. Momentum favours further upside here.
Expect NGVT to range from $88.24 to $149.26 through 2029. The $111.47 average target implies a +54% move from current prices. That is up +17% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NGVT price prediction for 2030 points to an average of $128.68 (low $100.51, high $175.41) — a potential gain of +78% on today's $72.19. Momentum favours further upside here.
In 2031, NGVT is projected to trade between $119.90 and $215.14, averaging $155.37 — a potential gain of +115% from today's $72.19. That is up +21% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Ingevity Corporation's 2032 outlook centres on $169.90, within a $129.64 to $238.60 range. That is up +9% on the projected 2031 average. That marks a +135% change versus current levels. Momentum favours further upside here.
By 2033, NGVT could reach as high as $253.14, with a base case around $177.95 and support toward $134.37 — roughly +147% from $72.19. Buyers look set to stay in control over this stretch.
Expect NGVT to range from $147.27 to $283.55 through 2034. The $196.97 average target implies a +173% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The NGVT price prediction for 2035 points to an average of $199.61 (low $147.85, high $290.56) — a potential gain of +177% on today's $72.19. Buyers look set to stay in control over this stretch.
In 2040, NGVT is projected to trade between $243.04 and $522.06, averaging $342.25 — a potential gain of +374% from today's $72.19. That is up +71% on the projected 2035 average. Momentum favours further upside here.
Ingevity Corporation's 2050 outlook centres on $682.03, within a $451.60 to $1,115.19 range. That is up +99% on the projected 2040 average. That marks a +845% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NGVT today (≈ 13.852334 NGVT) could be worth
$9,447.72
+$8,447.72 (+845%) by 2050 · US Dollar
Based on the average projected NGVT price of $682.03 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NGVTwould be worth at today's price.
$1,000 invested in NGVT on Jul 10, 2025 (≈ 20.738282 NGVT) would be worth
$1,497.1
+$497.1 (+49.7%) today · 1.50× · US Dollar
Based on a NGVT entry price of $48.22 vs. today's $72.19.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $72.49 | $995.86 | -0.4% |
| 1 month ago | $68.06 | $1,060.68 | +6.1% |
| 3 months ago | $75.25 | $959.34 | -4.1% |
| 6 months ago | $65.57 | $1,100.96 | +10.1% |
| 1 year ago | $48.22 | $1,497.1 | +49.7% |
| All time (5.0y) ago | $81.39 | $886.96 | -11.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NGVT forecast.
Our base-case forecast reaches $140.00 around 2031.
Implied market cap at $140.00: $4.87B
The multi-year forecast shows a clear upward trajectory for NGVT. In 2027 the average is $82.14 with a max of $104.88 and a min of $67.27, delivering a 14.8% ROI and a neutral sentiment. By 2028 the average rises to $94.48 and by 2029 to $110.45, with ROIs of 32.1% and 54.4% respectively, signaling accelerating upside.
For 2030, the forecast shows an average of $127.87 with a min of $99.87 and a max of $174.32, and an ROI of 78.8% in a bullish outlook. The path continues higher in 2031–2033, 2032’s average is $168.49, 2033’s $176.76, and 2034’s $195.31, all bullish with rising ROIs; 2035 shows $197.93 on average. By 2040, the average is $339.94 with a max of $518.57 and an ROI of 375.3%, continuing the bullish trend.
In 2050, the average reaches $676.32 with a max of $1,105.89, a min of $447.80, and an ROI of 845.5%, maintaining a bullish sentiment.
These figures illustrate a long‑term upside, but they are estimates, not guarantees. Investors should consider that outcomes depend on market conditions and other factors external to these projections.
Tap a question to reveal the answer.
The 2030 forecasted average price is $127.87, with a min of $99.87 and a max of $174.32; ROI is 78.8% and sentiment is bullish.
Forecasts show a bullish multi‑year path with rising averages and higher ROIs, including 2040 average of $339.94 with ROI of 375.3% and 2050 average of $676.32 with ROI of 845.5%; these are estimates, not guarantees.
Yes. The forecast includes a max of $104.88 in 2027 and a 2030 min of $99.87, so $100 is within the forecast range.
The current price is $71.53.
The 2050 forecast shows an average price of $676.32, a min of $447.80, a max of $1,105.89, and ROI of 845.5%; sentiment is bullish.
Ingevity Corporation Community Discussion
0Share your Ingevity Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.